Fifth Third Bancorp (NASDAQ:FITB) shares moved down -3.16% in last trading session and ended the day at $18.71. FITB has a return on assets of 1.00%. Fifth Third Bancorp (NASDAQ:FITB) quarterly performance is -1.10%.
Fifth Third Bancorp (NASDAQ:FITB) declared a cash dividend on its common shares of $0.13 for the fourth quarter of 2015. The dividend is payable on January 21, 2016 to shareholders of record as of December 31, 2015
Five Below, Inc. (NASDAQ:FIVE) ended the last trading day at $33.72. Company weekly volatility is calculated as 3.18% and price to cash ratio as 101.63. Five Below, Inc. (NASDAQ:FIVE) showed a weekly performance of 5.01%.
Five Below, Inc. (NASDAQ:FIVE) announced net sales results for the nine weeks ended January 2, 2016. The Company announced that net sales for the nine-week period ended January 2, 2016 increased by 24.0% to $286.1 million from $230.7 million in the comparable nine-week period of fiscal 2014, while comparable store sales for this period increased by 4.1% over the comparable period in fiscal 2014.
Celldex Therapeutics, Inc. (NASDAQ:CLDX) shares decreased -7.97% in last trading session and ended the day at $13.17. CLDX has a return on assets of -36.30%. Celldex Therapeutics, Inc. (NASDAQ:CLDX) quarterly performance is 10.12%.
Zacks Investment Research downgraded shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX) from a buy rating to a hold rating in a research report published on Monday morning, Market Beat reports.
Cleveland BioLabs, Inc. (NASDAQ:CBLI) shares moved down -9.65% in last trading session and ended the day at $3.37. Cleveland BioLabs, Inc. (NASDAQ:CBLI) quarterly performance is -24.27%.
Cleveland BioLabs, Inc. (NASDAQ:CBLI) said that, it provides an overview of the Cleveland BioLabs, Inc. ’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cleveland BioLabs, Inc., complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
International Business Machines Corporation (NYSE:IBM) caters to the Technology space. It has a net profit margin of 17.00% and weekly performance is -4.65%. On the last day of trading company shares ended up at $132.86. International Business Machines Corporation (NYSE:IBM) distance from 50-day simple moving average (SMA50) is -3.41%.
On 1 January, International Business Machines Corporation (NYSE:IBM) has done a great job marketing Watson, its cloud-based natural language processing cognitive computing platform. It famously started in 2011 with Ken Jennings and Jeopardy! and now is featured in television commercials with Jennings, a cute little girl who is in remission from cancer, Bob Dylan and others.
Leave a Reply